// App-Quantinova.ai

Mo1245 : Impact of Inflammatory Bowel Disease Activity on the Incidence of Non-Alcoholic Fatty Liver Disease: a 7-Year Longitudinal Study

Researchers

Presenter

  • Kathleen C. Rollet

Principal Investigators

  • Waqqas Afif

  • Alain Bitton

  • Talat Bessissow

  • Giada Sebastiani

Medical Centers

  • Chronic Viral Illlness Service, Department of Medicine, McGill University Health Center, McGIill University, Montreal, QC, Canada

  • Division of Gastroenterology and Hepatology, McGill University Health Center, McGill University, Montreal, Quebec, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • Nonalcoholic fatty liver disease

  • Inflammatory bowel disease

  • Fatty Liver Disease

  • Crohn's disease

Biomarkers

  • Aldo-keto Reductase Family 1 Member B10

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved